TRCT
BBNX

Tower Research Capital (TRC)’s Beta Bionics BBNX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30K Sell
2,991
-4,483
-60% -$66.3K ﹤0.01% 3167
2025
Q4 		$228K Buy
7,474
+6,209
+491% +$166K 0.01% 1348
2025
Q3 		$25.1K Sell
1,265
-1,119
-47% -$19.7K ﹤0.01% 3095
2025
Q2 		$34.7K Buy
2,384
+1,287
+117% +$18.2K ﹤0.01% 3283
2025
Q1 		$13.4K Buy
+1,097
New +$20.5K ﹤0.01% 3367

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tower Research Capital (TRC)'s BBNX Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Beta Bionics (BBNX) stake by 60% in Q1 2026, selling an estimated $66.3K and leaving 2,991 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #3167.

Tower Research Capital (TRC) first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $228K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Tower Research Capital (TRC) held 2,991 shares of Beta Bionics worth $30K as of Q1 2026.
  • Tower Research Capital (TRC) sold 4,483 Beta Bionics shares in Q1 2026, an estimated $66.3K.
  • Beta Bionics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3167 holding.
  • Tower Research Capital (TRC) first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Tower Research Capital (TRC)'s Beta Bionics position peaked at $228K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.